729-4 Left Ventricular Hypertrophy and the Deletion-Insertion Polymorphism of the Angiotensin Converting Enzyme Gene  by Levy, Daniel et al.
136A ABSTRACfS JACC February 1995
04:30
04:15
1729-21 Macrophage-Monocyte Invasion is Associated with
Greater Cardiac Hypertrophy in Hypertensive Rats
Thus, significant monocyte-macrophage invasion is a hitherto unrecog-
nized feature of cardiac hypertrophy in SHR rats. We speculate that growth
factors released by such cells may contribute to hypertensive cardiac hyper-
trophy.
No LVH LVH Odds Ratio 95% CI
(n = 2097) In = 375) (II reference)
DD 29.3% 31.2% 0.94 0.69--1.28
DI 51.5% 46.9% 0.80 0.6D-1.07
II 19.2% 21.9% 1.00
04:45
Analysis of 31 sib-pairs with LVH also revealed no association (P = 0.53)
with the D-I polymorphism.
We conclude that in the population-based sample of the Framingham Heart
Study, there is no association between the ACE D-I polymorphism and level
of LV mass or prevalence of LVH.
1729-41 Left Ventricular Hypertrophy and the Deletion-
Insertion Polymorphism of the Angiotensin
Converting Enzyme Gene
Daniel Levy, Klaus Lindpaintner, Martin G. Larson, Vasan S. Ramachandran,
Richard H. Myers, Marc A. Pfeffer, Jose M. Ordovas, Ernst J. Schaefer, Peter
WF. Wilson. Framingham Heart Study, Framingham, MA
A recent case-control study reported a higher odds of left ventricular hyper-
trophy (LVH) on ECG among subjects homozygous for the angiotensin con-
verting enzyme (ACE) gene deletion (D) polymorphism. We examined the re-
lations of the ACE deletion-insertion (D-I) polymorphism to echocardiograph-
ically defined LVH in 2472 subjects from the Framingham Heart Study (mean
age48.7 range 20to 86). LVH (defined as LVmass/height > 102g/m inwomen
and> 143 glm in men) was present in 15% of the study sample. Logistic re-
gression analyses revealed no relation between the DD genotype and LVH.
Association analyses also revealed no differences in mean levels of LV mass
among the three genotypes. These results did not differ after adjustment for
age, sex and obesity.
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1729-51 Involvement of AT1 Receptor SUbtype in Angiotensin
II Induced Ca2+ Releases in Rat Cardiac Myocytes
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Krishnankutty Sudhir, Rodney Dilley, Alex Bobik, Baker Medical Research Institute
and Alfred Hospital, Melbourne, Australia
Cardiac hypertrophy is an adaptive response to increased wall stress in hy-
pertension. Although the mechanisms underlying this adaptive response are
not clearly understood, a genetic predisposition appears to playa role. We
sought to examine the hypothesis that an inflammatory response occurs in
the heart early in the course of development of hypertension. We measured
blood pressure, heart weight and cardiac macrophage-monocyte invasion in
6 week old SHR and WKY rats with renal hypertension (1 Kidney-1 Clip, 1K-
1C) or sham-operated controls (SHAM). Macrocyte-monophage invasion was
measured as the extent of immunohistochemical staining with ED1, a cy-
toplasmic antigen in this cell type. Measurements were made at 7 and 21
days post procedure. Renal hypertensive rats, both SHR and WKY, had higher
blood pressures at both time points than SHR sham, which in turn had higher
blood pressures that WKY sham rats. Heart weight/body weight ratios were
highest in SHR-1 K1 C rats, followed by SHR SHAM and WKY 1K1 C, and least
in WKY sham rats. ED1 staining was also highest in SHR 1K-l C rats, followed
by SH R sham rats, and was considerably lower in WKY rats, 1K-1 C or sham.
Data atthe 21 daytime point are shown below:
1729-31 Left Ventricular Hypertrophy in Essential
Hypertension Depends on ACE Genotype
Kevin P.J. O'Kane, Neeraj Prasad 1, Heather A. Johnstone, Catherine Macleod 1,
Andrew D. McMahon 1, Thomas M. MacDonald 1, David J. Webb. University
Department ofMedicine, Western General Hospital, Edinburgh, Ninewells Hospital,
Dundee, Scotland: 1 Department of Clinical Pharmacology, Ninewells Hospital, Dundee,
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Introduction: A deletionlinsertion polymorphism in the ACE gene accounts
for approximately 50% of the variance in plasma angiotensin converting en-
zyme (ACE) concentration, and may be linked to tissue ACE activity. The
deletion allele (D) occurs with increased frequency in patients with hyper-
trophic and dilated cardiomyopathy. Left ventricular hypertrophy (LVHj is a
recognised complication of essential hypertension, and is associated with in-
creased morbidity and mortality. Angiotensin II, which is produced by ACE,
promotes myocyte growth and collagen deposition, and has been causally
linked with the development of LVH.
Aim: To examine the contribution of ACE genotype to the development of
left ventricular hypertrophy in patients with essential hypertension.
Method: Eighty-five consecutive patients (58 males, [59.5%]; mean age
53.8 years) attending the out-patient hypertension clinic were studied.
Blood pressure was measured using a semi-automatic sphygmomanome-
ter. Echocardiography was performed and left ventricular mass (indexed for
height and weight) was calculated from M-mode measurements according to
the Penn convention. DNA was extracted from peripheral blood leucocytes
by a commercially available method, and ACE genotype determined by the
polymerase chain reaction using standard primers and conditions.
Results:
J. Inamo, S. Sempe, L. Tariosse, B. Stuyvers, G. Gouverneur, P. Besse,
S. Banoran-Adele. Unite 8, INSERM, Universite Bordeaux II, Pessac, France
In previous studies, we have reported that angiotensin II (Ang II) induced oc-
currence of spontaneous calcium releases in rat cardiac myocytes, with an
increased sensitivity of hypertrophied myocytes. In this study, valsartan, a
non-peptide antagonist of Ang II ATl receptor subtype was used to assess
the involvement of the ATl receptors in Ca2+ release phenomena Ang II de-
pendant (1 0-7M). Freshly isolated left ventricular myocytes from normal and
hypertensive adult rats (RHR) were used. The variation of the ratio of Indo-1
emission (405nm/480nm) was taken as an index of intracellular Ca2+ varia-
tions on unstimulated or stimulated myocytes. Five parameters were mea-
sured from each Ca2+ transient: amplitude, duration with a rise time and a
fall time, and frequency of spontaneous calcium releases. From each cell, re-
sults are expressed as a percent change in baseline values.
In absence of Ang II, no significant effect was observed under valsartan
(10-10 M, 10-9 M and 10-8 M).ln unstimulated normal myocytes, the 450%
increase in frequency induced by Ang II is reduced by valsartan 10-9 M and
10-8 M (27% and 7% respectively; p < 0.01). A less pronounced inhibition
is observed in hypertrophied myocytes; the 485% increase caused by Ang II
is reduced to 206% and 184% Ip < 0.05). In stimulated myocytes, valsartan
(10- 10 M, 10-9 M and 10-8 M) inhibit the effects of Ang II on each parameter.
For example, the 68% increase in duration induced by Ang II in normal cells is
reduced respectively to 14% and -6% (p < 0.01); in hypertrophied myocytes
the 74% Ang II-induced increase is reduced to 6% and -1 % (p < 0.01).
Since the effects of Ang II on Ca2+ transients of rat cardiomyocytes are
completely inhibited by valsartan, our results suggest that Ang II dependent
Ca2+ transients are mediated by ATl receptors.
DD (n ~ 25) ID (n ~ 41) II (n = 19)
LVMI (g/M2 )! 116.1 (42.9) 116.5 (48.2) 108.0
(27.5)
SBP(mmHg)! 149.2 (224) 159.1 (286) 156.3 (265)
Relationship of
LVMI to SBP p < 0.001 P = 0.002 P = 0.729
D ~ ACE gene deletion allele; I = ACE gene insertion allele.
t Results expressed as mean ± standard deviation
Conclusion: There is a significant correlation between LVM and SSP in pa-
tients with the deletion allele, but not in homozygotes for the insertion al-
lele. The deletion homozygotes have a similar left ventricular mass to the het-
erozygotes, but for a lower mean SBP. These data suggest that systolic blood
pressure is a major determinant of left ventricular mass in hypertension, but
the relationship is expressed only in the presence of the deletion allele.
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1729-61 Deletion Polymorphism of the Angiotensin-
Converting Enzyme Gene is Associated with
Concentric Remodeling of the Left Ventricle
Ali G. Gharavi, Robert A. Phillips, Joseph A. Diamond, Jeffrey S. Jhang, Michael
S. Lipkowitz. Mount Sinai School of Medicine, New York, NY
There is polymorphism in the angiotensin-converting enzyme (ACE) gene, de-
fined by the insertion (I allele) or deletion (D allele) of a 287 base pairalu repeat
sequence. The DD genotype is associated with myocardial infarction, car-
diomyopathy and LVH on ECG. LVH and concentric remodeling, [increased
relative wall thickness (RWT»), significantly increase cardiovascular morbid-
ity and mortality. The current studies were performed to evaluate the rela-
tionship between the DD genotype and echocardiographic findings in an un-
